Literature DB >> 1588012

Response of 6-pyruvoyl-tetrahydropterin synthase deficiency to tetrahydrobiopterin.

A al Aqeel1, P T Ozand, G G Gascon, H Hughes, C T Reynolds, S B Subramanyam.   

Abstract

We have given tetrahydrobiopterin (BH4) in doses ranging from 2.5 to 20 mg/kg/day, each for a duration of 5 days to three patients with 6-pyruvoyltetrahydropterin synthase deficiency. As small a dose as 2.5 mg/kg/day BH4 reduced the blood phenylalanine to normal levels. However, the required dose of BH4 to reduce neopterin and to increase urine biopterin was 5 to 10 mg/kg/day, while 20 mg/kg/day was required for biopterin to appear in cerebrospinal fluid. The results suggest that BH4 effectively reduces endogenous neopterin synthesis. The dose of BH4 needed to normalize liver phenylalanine hydroxylase is one eighth to one fourth that required for normal neurotransmitter metabolism in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1588012

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  3 in total

Review 1.  Tetrahydrobiopterin as a novel therapeutic intervention for autism.

Authors:  Richard E Frye; Lynne C Huffman; Glen R Elliott
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

2.  Dihydropteridine reductase deficiency and treatment with tetrahydrobiopterin: a case report.

Authors:  Curtis R Coughlin; Keith Hyland; Rebecca Randall; Can Ficicioglu
Journal:  JIMD Rep       Date:  2012-12-29

Review 3.  Disorders of biopterin metabolism.

Authors:  Nicola Longo
Journal:  J Inherit Metab Dis       Date:  2009-02-09       Impact factor: 4.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.